TrialHepatology (Baltimore, Md.)2015

Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis.

Hiromitsu Kumada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.